跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 593 条关于
“CMML”
全部
593
临床试验
503
药物
6
机构
1
资讯
83
9个月前
Cardiff Oncology's PLK1 Inhibitor Onvansertib Shows Promise in CMML Trial and Advances Toward Phase III in Colorectal Cancer
去年
IO-202 Plus Azacitidine Shows Promise in Treating CMML
5年前
SL-401 Shows Promise in Advanced Myeloproliferative Neoplasms, Including CMML
3个月前
Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 in Chronic Myelomonocytic Leukemia
2年前
Taiho Oncology Announces Publication of Final Results from ASCERTAIN Clinical Trial
去年
FDA Lifts Clinical Hold on Seclidemstat Trial: 43% Response Rate Observed in Advanced Blood Cancer Study
5个月前
Mabwell Achieves Global First with NMPA Acceptance of Novel LILRB4/CD3 Bispecific Antibody for Blood Cancers
去年
Solu Therapeutics Appoints Enda Moran as COO to Scale CyTAC Platform Operations
9个月前
OncoPrecision's First-in-Class CD64-Targeting ADC ONC001 Selected for Oral Presentation at ASH 2025
去年
Salarius Pharmaceuticals' Seclidemstat Gains Validation as LSD1 Inhibitor in New Studies While Phase 1/2 Trial Advances
第 1 页,共 9 页
上一页
下一页